196 related articles for article (PubMed ID: 23856902)
1. The proteomics and interactomics of human erythrocytes.
Goodman SR; Daescu O; Kakhniashvili DG; Zivanic M
Exp Biol Med (Maywood); 2013 May; 238(5):509-18. PubMed ID: 23856902
[TBL] [Abstract][Full Text] [Related]
2. The human red blood cell proteome and interactome.
Goodman SR; Kurdia A; Ammann L; Kakhniashvili D; Daescu O
Exp Biol Med (Maywood); 2007 Dec; 232(11):1391-408. PubMed ID: 18040063
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte ATP, a possible therapeutic approach for sickle cell disease.
Hoffman JF
Am J Hematol; 2019 May; 94(5):E117. PubMed ID: 30681180
[No Abstract] [Full Text] [Related]
4. Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium.
Zhou Z; Thiagarajan P; Udden M; Lòpez JA; Guchhait P
Thromb Haemost; 2011 Jun; 105(6):1046-52. PubMed ID: 21437360
[TBL] [Abstract][Full Text] [Related]
5. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
Segel GB; Simon W; Lichtman MA
Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
[No Abstract] [Full Text] [Related]
6. A novel non-invasive method to measure splenic filtration function in humans.
El Hoss S; Dussiot M; Renaud O; Brousse V; El Nemer W
Haematologica; 2018 Oct; 103(10):e436-e439. PubMed ID: 29880604
[No Abstract] [Full Text] [Related]
7. Interactomics: toward protein function and regulation.
Feng S; Zhou L; Huang C; Xie K; Nice EC
Expert Rev Proteomics; 2015 Feb; 12(1):37-60. PubMed ID: 25578092
[TBL] [Abstract][Full Text] [Related]
8. Abnormal permeability pathways in human red blood cells.
Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion under flow.
Ley K
Microcirculation; 2009 Jan; 16(1):1-2. PubMed ID: 19191171
[TBL] [Abstract][Full Text] [Related]
10. Singer K, Fisher B. Studies on abnormal hemoglobins, VI: electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. Blood. 1953;8(3):270-275.
Blood; 2016 Feb; 127(7):791. PubMed ID: 26893392
[No Abstract] [Full Text] [Related]
11. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
Noguchi CT; Schechter AN
Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
[TBL] [Abstract][Full Text] [Related]
12. Red cell membrane injury in sickle cell anaemia.
Palek J
Br J Haematol; 1977 Jan; 35(1):1-9. PubMed ID: 322695
[No Abstract] [Full Text] [Related]
13. 2D DIGE based proteomics study of erythrocyte cytosol in sickle cell disease: altered proteostasis and oxidative stress.
Basu A; Saha S; Karmakar S; Chakravarty S; Banerjee D; Dash BP; Chakrabarti A
Proteomics; 2013 Nov; 13(21):3233-42. PubMed ID: 24030922
[TBL] [Abstract][Full Text] [Related]
14. Cluster analysis for the impact of sickle cell disease on the human erythrocyte protein interactome.
Ammann LP; Goodman SR
Exp Biol Med (Maywood); 2009 Jun; 234(6):703-11. PubMed ID: 19359656
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.
Dai Y; Sangerman J; Nouraie M; Faller AD; Oneal P; Rock A; Owoyemi O; Niu X; Nekhai S; Maharaj D; Cui S; Taylor R; Steinberg M; Perrine S
Am J Hematol; 2017 Jan; 92(1):E10-E11. PubMed ID: 27766663
[No Abstract] [Full Text] [Related]
16. A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders.
Pesciotta EN; Sriswasdi S; Tang HY; Mason PJ; Bessler M; Speicher DW
J Proteomics; 2012 Dec; 76 Spec No.(0 0):194-202. PubMed ID: 22954596
[TBL] [Abstract][Full Text] [Related]
17. Sickle red cell dehydration: mechanisms and interventions.
Bookchin RM; Lew VL
Curr Opin Hematol; 2002 Mar; 9(2):107-10. PubMed ID: 11844992
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic and molecular insights into sickle cell disease and innovative therapies.
Adebiyi MG; Manalo JM; Xia Y
Blood Adv; 2019 Apr; 3(8):1347-1355. PubMed ID: 31015210
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell proteomics.
Pasini EM; Mann M; Thomas AW
Transfus Clin Biol; 2010 Sep; 17(3):151-64. PubMed ID: 20655788
[TBL] [Abstract][Full Text] [Related]
20. Can new optical techniques for in vivo imaging and flow cytometry of the microcirculation benefit sickle cell disease research?
Morgan SP
Cytometry A; 2011 Oct; 79(10):766-74. PubMed ID: 21744494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
